摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(trimethylsilyl)ethyl O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1->3)-O-(2,4,6-tri-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside | 128716-23-4

中文名称
——
中文别名
——
英文名称
2-(trimethylsilyl)ethyl O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1->3)-O-(2,4,6-tri-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside
英文别名
GlcNAc(b1-3)[Bn(-2)][Bn(-4)][Bn(-6)]Gal(b1-4)[Bn(-2)][Bn(-3)][Bn(-6)]Glc(b)-O-EtTMS;N-[(2S,3R,4R,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5R,6R)-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)-6-(2-trimethylsilylethoxy)oxan-3-yl]oxy-3,5-bis(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
2-(trimethylsilyl)ethyl O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1->3)-O-(2,4,6-tri-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside化学式
CAS
128716-23-4
化学式
C67H83NO16Si
mdl
——
分子量
1186.48
InChiKey
FAEXNVMVXZKFNY-NBRUXRFXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.28
  • 重原子数:
    85
  • 可旋转键数:
    30
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    201
  • 氢给体数:
    4
  • 氢受体数:
    16

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • First total synthesis of α-(2→3)/α-(2→6)-disialyl lactotetraosyl ceramide and disialyl Lewis A ganglioside as cancer-associated carbohydrate antigens
    作者:Takayuki Ando、Hideharu Ishida、Makoto Kiso
    DOI:10.1016/s0008-6215(02)00465-2
    日期:2003.3
    Abstract The first total synthesis of α-(2→3)/α-(2→6)-disialyl lactotetraosyl (DSLc 4 ) ceramide and α-(2→3)/α-(2→6)-disialyl Lewis A (DSLe a ) ganglioside as cancer-associated antigens is described. The suitably protected lactotriose (Lc 3 ) derivatives were successively glycosylated with sialic acid, sialyl-α-(2→3)- d -galactose and/or l -fucose donors in a regio- and stereo-selective manner, to
    摘要α-(2→3)/α-(2→6)-二唾液酸乳糖四糖基(DSLc 4)神经酰胺和α-(2→3)/α-(2→6)-二唾液酸Lewis A(描述了DSLe a)神经节苷脂作为癌症相关抗原。将适当保护的乳三糖(Lc 3)衍生物以区域和立体选择性方式依次用唾液酸唾液酸-α-(2→3)-d-半乳糖和/或1-岩藻糖供体糖基化,得到被保护的I型六糖和七糖分别通过引入神经酰胺和随后的完全脱保护作用分别转化为目标神经节苷脂
  • Stereoselective synthesis of sialyl-lactotetraosylceramide and sialylneolactotetraosylceramide
    作者:Akihiko Kameyama、Hideharu Ishida、Makoto Kiso、Akira Hasegawa
    DOI:10.1016/0008-6215(90)84197-3
    日期:1990.4
    3)-6-O-benzoyl-beta-D-galactopyranosid e (1), via benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with methylthiotrimethylsilane. Coupling of 2-(trimethylsilyl) ethyl 2,3,6,2',4',6'-hexa-O-benzyl-beta-D-lactoside (8), prepared from 2-(trimethylsilyl)ethyl beta-D-lactoside (5) via selective 3'-O-(4-methoxybenzylation), benzylation, and
    描述了唾液酸基-乳基四糖基神经酰胺(28,IV3NeuAcLc4Cer)和唾液酸基神经元四糖基神经酰胺(32,IV3NeuAcnLc4Cer)的第一全部合成。O-(5-乙酰基甲基-4,7,8,9-四-O-乙酰基-3,5-二甲氧基-D-甘油-α-D-半乳糖-2-壬基喃二磺酸甲酯)-(2 ---- 3)-2,4,6-三-O-苯甲酰基-1-硫代-β-D-吡喃半乳糖苷(4)是关键的糖基供体,由2-(三甲基甲硅烷基)乙基O-(甲基5-乙酰基)制得-4,7,8,9-四-O-乙酰基-3,5-二脱氧-D-甘油-α-D-半乳糖-2-壬基喃二磺酸根)-(2 ---- 3)-6-O-苯甲酰基-β-D-喃半乳糖苷(1),通过苯甲酰化,用乙酰基取代2-(三甲基甲硅烷基)乙基,并用甲基三甲基硅烷引入甲基。2-(三甲基甲硅烷基)乙基2,3,6,2',4',6'-六-O-苄基-β-D-乳糖苷(8)的偶联,由
  • Synthesis of Sialyl-α-(2→3)-Neolactotetraose Derivatives Containing Different Sialic Acids: Molecular Probes for Elucidation of Substrate Specificity of Human α1,3-Fucosyltransferases
    作者:Eiji Tanahashi、Kyoko Fukunaga、Yuko Ozawa、Tsuyoshi Toyoda、Hidcharu Ishida、Makoto Kiso
    DOI:10.1080/07328300008544114
    日期:2000.1
    A series of sialyl-alpha-(2-->3)-neolactotetraose derivatives containing N-acetyl-(NeuAc), N-glycolyl- (NeuGc) and N-butanoylneuraminic acid, and 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN) have systematically been synthesized as molecular probes for elucidation of substrate specificity of human alpha 1,3-fucosyltransferases (Fuc-TVII and Fuc-TVI). 2-Methyl-(3,4, 6-tri-O-acetyl-1,2-dideoxy-alpha-D-glucopylano)-[2',1' :4,5]-2-oxazoline (1) was coupled with 2-(trimethyl-silyl)-ethyl (2,4,6-tri-O-benzyl-beta-D-galactopyranosyl) -(1 --> 4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside (2) to give a trisaccharide 3 which, upon successive O-deacetylation, benzylidenation and reductive opening of the benzylidene group, afforded a common glycosyl acceptor 5. Glycosylation of 5 with sialyl-alpha-(2-->3)-galactose donors 6-8, 19 and 21 gave the corresponding pentasaccharides 22-25, which were converted to a series of sialyl-alpha-(2-->3)-neolactotetraose derivatives 30-33. In the competitive enzyme assay, the NeuGc derivative 32 showed the most potent activity for Fuc-TVII, while the KDN derivative 31 was less active than the standard NeuAc derivative 30. In contrast, the N-butanoylation of neuraminic acid enhanced the activity for Fuc-TVI.
  • KAMEYAMA, AKIHIKO;ISHIDA, HIDEHARU;KISO, MAKOTO;HASEGAWA, AKIRA, CARBOHYDR. RES., 193,(1989) C1-C5
    作者:KAMEYAMA, AKIHIKO、ISHIDA, HIDEHARU、KISO, MAKOTO、HASEGAWA, AKIRA
    DOI:——
    日期:——
查看更多